Evidence for adrenalin secretion regardless of high extraglandular levels.
Chronic adrenalin administration (4 mg/18 hrs) by means of a subcutaneous depot capsule leads to hypoglycaemia and adrenalin depletion of the suprarenal gland within 18 hrs. Stimultaneous application of glucose prevents hypoglycemia as well as adrenalin depletion. By injection of 3H-labelled tyrosine 10, 20 or 30 min before killing and subsequent detection of the quantity of labelled tyrosine and adrenalin in the sera by mixing them with a standard solution containing considerable amounts of unlabelled tyrosine and adrenalin, and by passing them through a Sephadex G-10 column and finally detecting the radioactivity of the fractions in a liquid scintillation-counter, we could prove that during the stage of hypoglycaemia an enhanced adrenalin synthesis and secretion did take place regardless of a high extraglandular level. In animals treated with adrenalin and glucose, NaCl solution or alpha-methyl-tyrosine methylester-HCl no increased resp. no turnover at all could be seen. Therefore, we conclude that there is not only a lack of a direct negative feedback system between adrenalin synthesis, secretion and extraglandular level but also that the enhanced synthesis of adrenalin that can take place in spite of a high serum level can initiate a fatel circulus vitiosus.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D004343:Drug Implants; D004837:Epinephrine / Q000378:metabolism* / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism
D004343:Drug Implants; D008781:Methyltyrosines; D014443:Tyrosine; C022260:alpha-methyltyrosine methyl ester; D012965:Sodium Chloride; D005947:Glucose; D004837:Epinephrine